RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 11.75
0.00 (0.00%)
Jul 28, 2025, 12:47 PM GMT+1
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 7.29 million as of July 28, 2025. Its market cap has increased by 6.82% in one year.
Market Cap
7.29M
Enterprise Value
4.85M
Revenue
4.11M
Ranking
n/a
PE Ratio
7,292.08
Stock Price
11.75
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 7.29M, a decrease of -69.39%. That is a compound annual growth rate of -4.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 7.29M | 6.82% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | 33.72M | 127.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.50B |
| GSK plc | 56.21B |
| Haleon | 32.84B |
| Smith & Nephew | 10.27B |
| ConvaTec Group | 4.90B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.21B |
| Oxford Nanopore Technologies | 2.02B |